Trial Profile
Pharmacokinetic interaction safety of combination of elagolix and digoxin in healthy women: An open-label, two period crossover study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Sep 2017
Price :
$35
*
At a glance
- Drugs Elagolix (Primary) ; Digoxin
- Indications Endometriosis; Pelvic pain; Uterine leiomyoma
- Focus Adverse reactions; Pharmacokinetics
- 25 Sep 2017 New trial record
- 01 Sep 2017 Results published in the Clinical Pharmacology in Drug Development: 2017 Annual Meeting of the American College of Clinical Pharmacology.